Literature DB >> 8644846

Patterns of epidermal growth factor receptor amplification in malignant gliomas.

G Sauter1, T Maeda, F M Waldman, R L Davis, B G Feuerstein.   

Abstract

Amplification of the gene for epidermal growth factor receptor (EGFR) is a common finding in malignant gliomas. We found that 18 of 29 grade 3 and grade 4 gliomas had EGFR amplification when assayed using fluorescence in situ hybridization. The amplification pattern suggests that the amplicon is contained within double minute chromosomes in most cases. EGFR copy number can differ by 20-fold in amplified cells within a single case. Polysomy 7 occurs frequently in both EGFR-amplified and -unamplified cells. More than one-third of the cases had < or = 10 percent of cells with amplified EGFR, and it is likely that these cases would not have been identified by methods that do not examine DNA on a cell by cell basis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8644846      PMCID: PMC1861518     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Expression of epidermal growth factor receptors (EGFR) on breast carcinomas in relation to growth fractions, estrogen receptor status and morphological criteria. An immunohistochemical study.

Authors:  F Wrba; A Reiner; E Ritzinger; J H Holzner; G Reiner
Journal:  Pathol Res Pract       Date:  1988-02       Impact factor: 3.250

2.  Clonal genomic alterations in glioma malignancy stages.

Authors:  C D James; E Carlbom; J P Dumanski; M Hansen; M Nordenskjold; V P Collins; W K Cavenee
Journal:  Cancer Res       Date:  1988-10-01       Impact factor: 12.701

Review 3.  Cytogenetics of human brain tumors.

Authors:  S H Bigner; J Mark; D D Bigner
Journal:  Cancer Genet Cytogenet       Date:  1990-07-15

4.  Involvement of chromosomes 1, 3, and i(8q) in lung adenocarcinoma.

Authors:  M J Bello; S Moreno; J A Rey
Journal:  Cancer Genet Cytogenet       Date:  1989-03

5.  Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system.

Authors:  G Reifenberger; R Prior; M Deckert; W Wechsler
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

6.  Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification.

Authors:  A J Ekstrand; N Longo; M L Hamid; J J Olson; L Liu; V P Collins; C D James
Journal:  Oncogene       Date:  1994-08       Impact factor: 9.867

7.  Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification.

Authors:  A J Wong; S H Bigner; D D Bigner; K W Kinzler; S R Hamilton; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

8.  Characterization of node-negative breast cancer by clinico-pathologic and biologic factors.

Authors:  G Gasparini; P Bevilacqua; S Dal Fior; G A Panizzoni; S Favretto; A Visonà; S Meli
Journal:  Anticancer Res       Date:  1990 Jan-Feb       Impact factor: 2.480

9.  Expression of epidermal growth factor receptor in human breast carcinoma and its correlation with morphological and biological features of tumour aggressiveness.

Authors:  P G Betta; F Robutti; G Spinoglio; G Bottero
Journal:  Pathologica       Date:  1989 Jul-Aug

10.  Heterogeneity and modulation of tumor-associated antigens in human glioblastoma cell lines.

Authors:  M Colombatti; B Dipasquale; L Del-l'Arciprete; M Gerosa; G Tridente
Journal:  J Neurosurg       Date:  1989-09       Impact factor: 5.115

View more
  27 in total

1.  Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers.

Authors:  Luc G T Morris; Barry S Taylor; Trever G Bivona; Yongxing Gong; Stephanie Eng; Cameron W Brennan; Andrew Kaufman; Edward R Kastenhuber; Victoria E Banuchi; Bhuvanesh Singh; Adriana Heguy; Agnes Viale; Ingo K Mellinghoff; Jason Huse; Ian Ganly; Timothy A Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

2.  Synthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFR.

Authors:  Xiaogang Pan; Gong Wu; Weiliang Yang; Rolf F Barth; Werner Tjarks; Robert J Lee
Journal:  Bioconjug Chem       Date:  2007 Jan-Feb       Impact factor: 4.774

3.  Targeted signal-amplifying enzymes enhance MRI of EGFR expression in an orthotopic model of human glioma.

Authors:  Mohammed S Shazeeb; Christopher H Sotak; Michael DeLeo; Alexei Bogdanov
Journal:  Cancer Res       Date:  2011-01-18       Impact factor: 12.701

4.  PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis.

Authors:  Nina Ilic; Tamara Utermark; Hans R Widlund; Thomas M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

5.  Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.

Authors:  Tejus A Bale; Justin T Jordan; Otto Rapalino; Nisha Ramamurthy; Nicholas Jessop; John C DeWitt; Valentina Nardi; Maria Martinez-Lage Alvarez; Matthew Frosch; Tracy T Batchelor; David N Louis; A John Iafrate; Daniel P Cahill; Jochen K Lennerz
Journal:  Neuro Oncol       Date:  2019-05-06       Impact factor: 12.300

6.  Association between EGF +61 G/A and glioma risk in a Chinese population.

Authors:  Shujie Wang; Yao Zhao; Zhenchao Ruan; Hongyan Chen; Weiwei Fan; Juxiang Chen; Qihan Wu; Ji Qian; Tianbao Zhang; Yan Huang; Daru Lu
Journal:  BMC Cancer       Date:  2010-05-21       Impact factor: 4.430

7.  Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.

Authors:  Sasha Gulati; Borgny Ytterhus; Unn S Granli; Michel Gulati; Stian Lydersen; Sverre H Torp
Journal:  Diagn Pathol       Date:  2010-03-23       Impact factor: 2.644

Review 8.  Extracellular vesicles shed by glioma cells: pathogenic role and clinical value.

Authors:  Dimitry A Chistiakov; Vladimir P Chekhonin
Journal:  Tumour Biol       Date:  2014-06-27

9.  Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma.

Authors:  Yingqun Tao; Guobiao Liang
Journal:  Tumour Biol       Date:  2013-08-21

Review 10.  Rat brain tumor models to assess the efficacy of boron neutron capture therapy: a critical evaluation.

Authors:  Rolf F Barth; Weilian Yang; Jeffrey A Coderre
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.